Theoretically, treatment with GLP-2 could reduce the rapid gastric emptying and hypersecretion and increase the intestinal absorption in short bowel syndrome (SBS) patients. Here, GCG is linked to macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.